Market Might Still Lack Some Conviction On KoBioLabs, Inc (KOSDAQ:348150) Even After 36% Share Price Boost
The KoBioLabs, Inc (KOSDAQ:348150) share price has done very well over the last month, posting an excellent gain of 36%. Longer-term shareholders would be thankful for the recovery in the share price since it’s now virtually flat for the year after the recent bounce.
In spite of the firm bounce in price, KoBioLabs may still be sending very bullish signals at the moment with its price-to-sales (or “P/S”) ratio of 1.9x, since almost half of all companies in the Biotechs industry in Korea have P/S ratios greater than 15x and even P/S higher than 56x are not unusual. However, the P/S might be quite low for a reason and it requires further investigation to determine if it’s justified.
